Nagham Writes · The valuation desk
Watchlist
Four companies enter the week. Each is being tested against valuation, business quality, catalysts and downside risk.
This week’s research slate
Vote for Next Week’s Under the Microscope
Choose ADBE, CLS, CBRS or UNH for the October 18 edition. Voting closes Saturday, October 17, 2026 at 11:59 p.m. ET. Completed Under the Microscope subjects leave the poll; ORCL is our editorial selection for October 11.
Reader vote result
0 votes recorded.
- ADBE0%
- CLS0%
- CBRS0%
- UNH0%
Previous voting rounds
October 5–10, 2026 · Closed October 10
This round was closed during the weekly editorial refresh. Oracle was selected editorially for October 11.
Reader vote result
4 votes recorded.
- ADBE50%
- CLS25%
- CBRS25%
- UNH0%
September 27 round · Archived
Vistra received the most votes: 4 of 10 (40%).
Reader vote result
10 votes recorded.
- META30%
- ORCL10%
- VST40%
- UNH20%
- ZTS0%
- TTD0%
This week’s candidates
Select a company to view its research checklist.
Healthcare · UNHUnder review
UnitedHealth Group
Is the earnings recovery strong enough to outweigh medical-cost, Medicare and regulatory risk?
Research stage: normalization in progress
The question we must answer
A lower share price is not proof of value. We must determine whether UnitedHealth can restore durable owner earnings without relying on unusually favorable medical-cost assumptions.
Research checklist
- Normalized earnings
- Cash generation
- Balance sheet
- Business quality
- Intrinsic valuation
- Risk test
Software · ADBECandidate
Adobe
Can a deeply reset valuation and durable creative franchise outweigh AI-disruption and slower-growth concerns?
Research stage: initial screen
The question we must answer
Adobe is consolidating near a long-term low. We need to test whether recurring revenue, cash generation and AI monetization can support a re-rating without assuming the competitive risk away.
Research checklist
- Normalized earnings
- Cash generation
- Balance sheet
- Business quality
- Intrinsic valuation
- Risk test
AI Infrastructure · CLSCandidate
Celestica
Strong AI-infrastructure growth meets a constructive technical base—but valuation leaves less room for error.
Research stage: initial screen
The question we must answer
Celestica’s growth is strong, but the valuation already assumes substantial execution. We need to test whether AI-networking demand, earnings growth and cash generation can support another leg higher.
Research checklist
- Normalized earnings
- Cash generation
- Balance sheet
- Business quality
- Intrinsic valuation
- Risk test
AI Infrastructure · CBRSCandidate
Cerebras Systems
Can commercial demand broaden enough to justify the valuation beyond a concentrated set of major AI customers?
Research stage: initial screen
The question we must answer
Cerebras has a compelling inference-speed proposition, but the thesis needs broader commercial adoption. We will test customer concentration, capacity expansion, cash economics and valuation against contracted demand.
Research checklist
- Normalized earnings
- Cash generation
- Balance sheet
- Business quality
- Intrinsic valuation
- Risk test
Animal Health · ZTSCandidate
Zoetis
A durable business where valuation matters as much as quality.
Research stage: initial screen
The question we must answer
Recurring demand, pricing power and strong margins support the quality case. We still need to determine whether normalized growth and competitive advantages justify the price investors are paying.
Research checklist
- Normalized earnings
- Cash generation
- Balance sheet
- Business quality
- Intrinsic valuation
- Risk test
Advertising · TTDCandidate
The Trade Desk
Can the open-web advertising thesis translate into renewed operating momentum?
Research stage: initial screen
The question we must answer
We need to separate structural opportunity from execution. Revenue growth, client retention, margins and competition from large closed platforms must support the valuation.
Research checklist
- Normalized earnings
- Cash generation
- Balance sheet
- Business quality
- Intrinsic valuation
- Risk test
October 12–16, 2026 · Additional research
Stocks on Our Radar
These names are being monitored separately from the four reader-voting candidates. Inclusion signals a research question, not a buy recommendation or a completed valuation.
Watch customer concentration, smartphone-related demand, margins and whether cash generation supports the valuation. The key test is how much growth is already priced in.
Gold and copper exposure through an operating miner—not the same risk as holding bullion. Monitor realized metal prices, production costs, mine execution, free cash flow and geopolitical risk. Barrick changed its NYSE ticker from GOLD to B in May 2025.
Track travel demand, premium-cabin revenue, fuel costs, debt reduction and management guidance. The central question is whether earnings power justifies cyclical airline risk.
How a company earns a place on the qualified Watchlist
- Normalize earnings and cash flow.
- Check debt, dilution and accounting quality.
- Test the durability of the business.
- Build conservative, base and optimistic scenarios.
- Cross-check cash-flow value against comparable multiples.
- Require a meaningful margin for error.